Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit
NCT07642076
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
58
Enrollment
OTHER
Sponsor class
Conditions
Hepatic
Interventions
DRUG:
L Carnitine
DRUG:
Standard medical treatment
Sponsor
Beni-Suef University